Axsome Therapeutics Inc (NASDAQ:AXSM)
| 68.34 Delayed Data As of 3:59pm ET |  -3.69 / -5.12%Today’s Change | 35.44 Today|||52-Week Range 109.53 | -16.12% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -10.6M | -27.2M | -28.9M | -31.0M | |
| Depreciation | 3.5K | 20.5K | 42.6K | 48.9K | ||
| Total Other Cash Flow | 2.2M | 2.1M | 3.2M | -660.4K | ||
| Funds From Operations | -8.4M | -25.1M | -25.7M | -31.6M | ||
| Funds From/For Other Operating Expenses | -937.7K | -3.8M | 759.5K | -1.5M | ||
| Net Cash Flow - Operating Activities | -7.4M | -21.3M | -26.5M | -30.1M | ||
| Investing | Capital Expenditures | -20.2K | -104.6K | -9.9K | -32.7K | |
| Net Cash Flow Investing | -20.2K | -104.6K | -9.9K | -32.7K | ||
| Financing | Short Term Borrowings | -41.5K | 0.00 | 0.00 | 0.00 | |
| Long Term Borrowings | 7.4M | 9.9M | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -- | 0.00 | -277.8K | -3.3M | ||
| Net Proceeds Stock Sale | 45.5M | 33.0K | 24.2M | 13.4M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 26.0K | ||
| Net Cash Flow - Financing | 52.9M | 10.0M | 23.9M | 10.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 45.4M | -11.4M | -2.6M | -20.1M | ||
